 | Organogenesis Holdings Inc. | |||
| NCM : ORGO || Location: United States | ||||
$2.86+0.07 (+2.51%) |
0.79 M | 2.77 - 2.88 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 7.228 M |
| March 15, 2024 | 8.011 M |
| Feb. 29, 2024 | 7.566 M |
| Feb. 15, 2024 | 7.468 M |
| Jan. 31, 2024 | 6.706 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | 0.01 | 0.02 | 292.16% |
| 06/30/2023 | 0.03 | 0.04 | 56.86% |
| 03/31/2023 | -0.02 | -0.02 | 1.96% |
| 12/31/2022 | 0.05 | 0.06 | 17.65% |
| 09/30/2022 | 0.06 | 0.00 | -100.00% |
ORGO Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 131.963M | Shares Float | 61.838M |
| Short Float | 7.228M | Market Cap | 377.41M |
| Institution ownership | 44.96% | Insider ownership | 33.321% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 0.04 | Forward EPS | 0.06 |